| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner | Director +2 more
43 companies
Ra Capital Management, L.P. is a Director, 10% Owner at Wave Life Sciences Ltd. with holdings across 43 companies. Recent SEC Form 4 filings include 13 buys and 5 sells.
Estimated insider holdings value: $3503.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 13, 2020 | KALA Kala Bio, Inc. | Director, 10% Owner | Buy | 6,337,135 | $7.89 | $49,999,995.15 | +139.7% | |
| Jan 24, 2019 | WVE Wave Life Sciences Ltd. | Director, 10% Owner | Buy | 263,158 | $38.00 | $10,000,004.00 | +3.5% | |
| Oct 3, 2018 | KALA Kala Bio, Inc. | Director, 10% Owner | Buy | 2,424,242 | $8.25 | $19,999,996.50 | +114.7% | |
| Oct 1, 2018 | ARVN Arvinas, Inc. | Former 10% Owner | Buy | 1,000,000 | $16.00 | $16,000,000.00 | +46.8% | |
| Nov 14, 2017 | WVE Wave Life Sciences Ltd. | Director, 10% Owner | Buy | 423,398 | $23.34 | $9,881,549.66 | +2.9% | |
| Oct 12, 2017 | KALV Kalvista Pharmaceuticals, Inc. | Director, 10% Owner | Buy | 850,000 | $8.50 | $7,225,000.00 | +143.8% | |
| Jul 25, 2017 | KALA Kala Bio, Inc. | Director | Buy | 533,333 | $15.00 | $7,999,995.00 | +33.8% | |
| Sep 16, 2016 | ACRS Aclaris Therapeutics, Inc. | 10% Owner | Sell | 525,550 | $24.19 | $12,713,502.44 | -4.4% | |
| Feb 23, 2016 | ACRS Aclaris Therapeutics, Inc. | 10% Owner | Buy | 39,726 | $17.15 | $681,469.87 | +0.8% | |
| Jan 20, 2016 | ACRS Aclaris Therapeutics, Inc. | 10% Owner | Buy | 7,803 | $19.87 | $155,072.47 | +0.1% |